Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Over the past few decades, numerous animal studies have tested BPC-157 in different injury models from torn tendons to toxic liver damage with remarkable results
Cagrilintide mimics amylin, a different hormone, and acts on amylin/calcitonin receptors
Molecular Characteristics Molecular Type: Synthetic retro-inverso peptide Structure: Linear peptide with D-amino acid configuration Research Name: FOXO4-DRI (Proxofim) Form: Lyophilized peptide powder Design: Derived from FOXO4 transcription-factor interaction sequence Stability: Enhanced resistance to enzymatic degradation Stability Profile and Storage Recommendations Supplied as a lyophilized peptide for long-term storage stability Recommended storage temperature: 20C Protect from humidity and direct light exposure Avoid repeated freezethaw cycles Reconstituted solutions remain stable for approximately 2448 hours under refrigeration Solubility and Reconstitution Options Sterile bacteriostatic water Buffered aqueous solutions Sterile saline solutions Phosphate-buffered saline (PBS) Analytical-grade laboratory buffers Technical Specifications product Name FOXO4-DRI (Proxofim) 10mg brand Biopeptides cas N/A purity 99% (HPLC validated) unit Size 10 mg form Lyophilized powder synthesis Solid-Phase Peptide Synthesis (SPPS) analytical HPLC, Mass Spectrometry molecular Structure Retro-inverso synthetic peptide stability High when stored appropriately Analytical Validation and Quality Assurance High-Performance Liquid Chromatography (HPLC) purity verification Mass Spectrometry molecular identity confirmation Batch-to-batch consistency validation Quality control testing for research reliability Analytical documentation available for laboratory records Regulatory and Compliance Statement FOXO4-DRI (Proxofim) 10mg is supplied strictly for laboratory research and scientific investigation
Common Misconceptions Immediate Effects: The belief that one single procedure will transform you overnight is not true
formulaciones especficas y combinaciones pueden estar patentadas por desarrolladores
